Singderm® consists of modified hyaluronic acid(HA) produced by bacteria and 0.3% lidocaine, formulated to a concentration of 24mg/ml in a physiologic buffer.
Singderm | |
Cross-linked agent | DVS |
Formulation process | Mono-phasic |
Concentration | 24mg/ml |
Composition | Hyaluronic acid and 0.3% lidocaine |
Specification | 1ml, 2ml, 10ml |
Depth of Injection | Middle or deep of dermis |
Duration | More than 12 months |
Certificate: CE, NMPA
Compared with biphasic dermal filler, Singderm®, a monophasic dermal filler, is more solid and durable and can provide better support and lift due to good viscoelasticity. Besides, it is easy to be pushed through a needle.
Recommended area for injection:
BD HylokTM Glass Pre-fillable Syringe is adopted to offer optimized user experience during the injection of Singderm®.
Injection of hyaluronic acid exerts a high pressure on the syringe, due to the viscosity of hyaluronic acid. 45% of dermatologists identified leakage as the main problem with hyaluronic acid syringes. So we choose BD glass over plastic syringes.
Superior performance can be provided by BD Hylok™, which thanks to:
•Its patented strongly affixed LLA for safe and robust needle connection
• Its intuitive screw-on tip cap, preferred by users over a standard clip-on tip cap